Richard Condon, CEO Aspire Pharma, discusses successful leadership ...

The great NHS prescribing lottery. Imagine a patient in Manchester receiving a cutting-edge medication, while another in ...

The recent landmark ruling by the UK’s Supreme Court – that the term “sex” in the Equality Act 2010 refers to biological sex, ...

Over the past two decades, clinical trials have undergone significant transformation. Historically, trials followed a ...

As Europe’s adoption of the IDMP data model advances, EMA’s centralised Product Management Services (PMS) platform is coming ...

In a sector defined by innovation, evidence and outcomes, the true catalyst for transformation is often overlooked: ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending mirikizumab (Omvoh) ...

Emerging evidence reveals a clinically significant rebound effect following the discontinuation of glucagon-like peptide-1 ...

The National Institute for Health and Care Excellence (NICE) has published updated guidance recommending Forxiga ...

What else is there to share? As it happens, quite a lot. Last time I spoke about the diagnosis of Young Onset Parkinson’s disease (YOPD), how this presented several day-to-day challenges from securing ...

The Board of the Medicines and Healthcare products Regulatory Agency (MHRA) has met in Scotland for the first time, marking a ...

Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of non-opioid medicines ...